Answers are grounded in this paper and cite their sources.
Investigates Bmal1's effect on retinal health in diabetes, suggesting new management strategies.
Our study highlights the therapeutic potential of central overexpression of a clock gene, Bmal1, to mitigate metabolic and neurovascular deficits of type 2 diabetes, offering a compelling framework for incorporating circadian rhythms into managing diabetes and its complications.
No takes yet. Share an insight, caveat, or question.
Mahajan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: